Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemosuppression of breast cancer with tamoxifen: laboratory evidence and future clinical investigations.

× No keyword cloud information.

19 in total

1. Beyond raloxifene for the prevention of osteoporosis and breast cancer.

Authors: V C Jordan
Journal: Br J Pharmacol Date: 2006-11-20 Impact factor: 8.739

Review 2. The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens.

Authors: D A Tonetti; V C Jordan
Journal: J Mammary Gland Biol Neoplasia Date: 1999-10 Impact factor: 2.673

3. The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.

Authors: V Craig Jordan; Ifeyinwa Obiorah; Ping Fan; Helen R Kim; Eric Ariazi; Heather Cunliffe; Hiltrud Brauch
Journal: Breast Date: 2011-10 Impact factor: 4.380

Review 4. Long-term adjuvant tamoxifen therapy for breast cancer.

Authors: V C Jordan
Journal: Breast Cancer Res Treat Date: 1990-05 Impact factor: 4.872

5. Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance.

Authors: Gregor M Balaburski; Rita C Dardes; Michael Johnson; Bassem Haddad; Fang Zhu; Eric A Ross; Surojeet Sengupta; Andres Klein-Szanto; Hong Liu; Eun Sook Lee; Helen Kim; V Craig Jordan
Journal: Int J Oncol Date: 2010-08 Impact factor: 5.650

Review 6. The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.

Authors: Ping Fan; Philipp Y Maximov; Ramona F Curpan; Balkees Abderrahman; V Craig Jordan
Journal: Mol Cell Endocrinol Date: 2015-06-05 Impact factor: 4.102

Review 7. New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors: V Craig Jordan
Journal: Steroids Date: 2007-07-27 Impact factor: 2.668

Review 8. Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.

Authors: V Craig Jordan; Joan Lewis-Wambi; Helen Kim; Heather Cunliffe; Eric Ariazi; Catherine G N Sharma; Heather A Shupp; Ramona Swaby
Journal: Breast Date: 2007-08-24 Impact factor: 4.380

Review 9. Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene.

Authors: Luigi Gennari; Daniela Merlotti; Ranuccio Nuti
Journal: Clin Interv Aging Date: 2010-02-02 Impact factor: 4.458

Review 10. Tamoxifen: catalyst for the change to targeted therapy.

Authors: V Craig Jordan
Journal: Eur J Cancer Date: 2008-01 Impact factor: 9.162